Alan Lotvin's Net Worth
$18.3 Million
Who is Alan Lotvin?
Alan Lotvin has an estimated net worth of $18.3 Million. This is based on reported shares across multiple companies, which include CVS HEALTH Corp, MAGELLAN HEALTH SERVICES INC, and PROKIDNEY CORP..
SEC CIK
Alan Lotvin's CIK is 0001472795
Past Insider Trading and Trends
2022 was Alan Lotvin's most active year for acquiring shares with 8 total transactions. Alan Lotvin's most active month to acquire stocks was the month of February. 2011 was Alan Lotvin's most active year for disposing of shares, totalling 9 transactions. Alan Lotvin's most active month to dispose stocks was the month of March. 2021 saw Alan Lotvin paying a total of $10,702,188.44 for 242,445 shares, this is the most they've acquired in one year. In 2022 Alan Lotvin cashed out on 367,781 shares for a total of $20,324,392.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CVS HEALTH Corp (CVS) Snapshot price: $57.5
EVP&President-PharmacyServices
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$78.22 | -$5,946,421.88 | 109.18K |
Scheduled
|
Aug 3 - Aug 4
| ||
Form 4
| -25.88% | -38.13K |
$101.09 | -$3,854,460.61 | 109.18K |
Apr 1
| |||
Form 4
| +140.15% | 85.97K |
—
|
—
| 147.31K |
Feb 21
| |||
Form 4
|
—
|
0
|
$104.38 | -$90,633.87 | 61.34K |
Scheduled
|
Feb 1
| ||
Form 4
| -3.32% | -200.00 |
$88.78 | -$17,756.00 | 5.83K |
Dec 27
| |||
Form 4
| -4.36% | -2.78K |
$83.67 | -$232,686.27 | 61.05K |
Scheduled
|
Jun 28
| ||
Form 4
| -2.60% | -1.71K |
$74.30 | -$126,681.50 | 63.83K |
Apr 3
| |||
Form 4
| +629.84% | 53.24K |
—
|
—
| 61.69K |
Feb 1 - Apr 1
| |||
Form 4
|
—
|
0
|
$70.72 | -$221,353.56 | 8.37K |
Scheduled
|
Jan 8
| ||
Form 4
| -47.08% | -7.14K |
$70.00 | -$499,660.00 | 8.02K |
Scheduled
|
Nov 13
| ||
Form 4
| +49.21% | 5K |
$63.14 | $315,675.00 | 15.16K |
May 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| -12.72% | -1.48K |
$58.34 | -$86,401.54 | 10.16K |
Apr 1
| |||
Form 4
| +47.47% | 11.67K |
$59.18 | $690,512.24 | 36.25K |
Feb 28
| |||
Form 4
| -10.22% | -863.00 |
$54.19 | -$46,765.97 | 7.58K |
Apr 1
| |||
Form 4
| +41.44% | 6.05K |
$57.83 | $349,871.50 | 20.65K |
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MAGELLAN HEALTH SERVICES INC No price found
President, ICore Healthcare
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.66% | -116.00 |
$46.96 | -$18,153.40 | 733 |
Scheduled
|
Apr 28
| ||
Form 4
|
—
|
0
|
$41.41 | -$126,711.42 | 849 |
Scheduled
|
Apr 4
| ||
Form 4
| +195.82% | 562 |
$48.74 | -$14,719.48 | 849 |
Mar 4
| |||
Form 4
| +37.32% | 78 |
$48.10 | -$2,020.20 | 287 |
Mar 5
| |||
Form 4
| +37.32% | 78 |
$48.10 | -$2,020.20 | 287 |
Mar 5
| |||
Form 4
| -80.74% | -876.00 |
$41.87 | -$178,209.40 | 209 |
Scheduled
|
Nov 8
| ||
Form 4
| +7.53% | 76 |
$43.34 | -$1,950.30 | 1.08K |
Mar 5
| |||
Form 4
| +115.14% | 540 |
$42.57 | -$13,792.68 | 1.01K |
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PROKIDNEY CORP. (PROK) Snapshot price: $2.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |